Delivery Order SPE2DB25D3404-SPE2DB25FUMAN

Award Date 2/12/25
Potential Completion Date 2/13/25
Potential Value $5.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $34,125.26 firm fixed-price delivery order is for "WEZLANA 90 MG/ML SYRINGEML" medical supplies, with a completion date of February 11, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, a primary vehicle for providing a comprehensive range...
This federal contract award, valued at $30,705.17, was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of "WEZLANA 90 MG/ML SYRINGEML" medical supplies and has a completion date of February 6, 2025. The contract is a Firm Fixed Price Delivery Order, with no set-aside designation, indicating open competition. AmerisourceBergen holds a significant Indefinite...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $21,605.00 fixed-price delivery order is for the supply of "WEZLANA 90 MG/ML SYRINGEML" medical products. The contract has an ultimate completion date of February 13, 2025. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as the...
This federal contract award, valued at $13,914.06, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order (DO) with a Firm Fixed Price (FFP) pricing type and an ultimate completion date of February 12, 2025. The contract covers the supply of "WEZLANA 90 MG/ML SYRINGEML", a pharmaceutical product, to support military healthcare programs. Amerisourcebergen...
This federal contract award, valued at $11,616.48, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order to supply the DLA with 4567238408 WEZLANA 90 MG/ML SYRINGEML, a medical product, with a period of performance through February 12, 2025. This award is not associated with a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The $2,409.70 firm-fixed-price contract is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of February 12, 2025. AmerisourceBergen holds a...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,617.43 firm-fixed-price contract is for the supply of various pharmaceutical products and medical supplies, including specialty medications, generic drugs, vaccines, syringes, and other medical commodities. The contract has an ultimate completion date of October 17, 2024. AmerisourceBergen holds a larger...
This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $20,534.86, is a firm fixed-price delivery order that covers a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of December 11, 2024....
This is a delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $41,215.15 firm fixed-price contract is for the delivery of a range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of February 11, 2025....
This federal contract award, valued at $111,908.16, was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order under the company's existing Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, worth up to $999,999,999 through November 2026. This IDC serves as a primary vehicle for AmerisourceBergen to provide a comprehensive range of pharmaceutical...
  • SPE2DB25D3404
    Indefinite Delivery Contract
  • SPE2DB25D3404-SPE2DB25FUMAN
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,568.57, is for the supply of "WEZLANA 90 MG/ML SYRINGEML" medical products. It is a firm fixed-price contract with a completion date of February 13, 2025.

AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The company also maintains a separate IDC with the Department of Justice Federal Bureau of Investigation, valued at $750,000 through May 2024, which covers similar medical products and prescription drugs. These IDCs enable efficient government procurement of essential pharmaceutical and medical supplies for military personnel, veterans, and other federal beneficiaries.

The contract award was not designated with a set-aside requirement, indicating open competition.

Generated 5/14/25, 10:18 AM